{"title":"基于糖胺聚糖乳剂的新型免疫治疗工具的设计原理","authors":"M. Ruggiero, S. Pacini","doi":"10.15761/ICST.1000285","DOIUrl":null,"url":null,"abstract":"In this article, we describe the rationale behind the design of an innovative immunotherapeutic tool designated imunoTM that is an emulsion of microbial, lowmolecular-weight chondroitin sulfate non-covalently bound to pure phosphatidylcholine with vitamin D3 intercalated in the ensuing multi-molecular structure. The rationale for this design derives from the decade-old observation that chondroitin sulfate is the active principle responsible for the immune-stimulatory, anti-cancer properties of cartilage extracts and from the more recent observation that a known immunotherapeutic compound, the Gc protein-derived Macrophage Activating Factor (GcMAF), works as an adjuvant similar, in principle, to the incomplete Freund’s adjuvant. From these premises, we designed an innovative tool that uses an ultrapure, low-molecular-weight chondroitin sulfate, thus overcoming all limitations associated with blood-derived or animal-derived non-ultrapure extracts, at the same time guaranteeing constant sulfation profile and charge density. This novel form of chondroitin sulfate is non-covalently bound to pure phosphatidylcholine in a self-assembly manner that is coherent with the principles of negentropy. Vitamin D3 is then intercalated in this structure that resembles protocells made of a phosphatidylcholine bilayer. Such an association reduces the main side effect of vitamin D3 that is the induction of hypercalcemia, at the same time maximizing its immunotherapeutic potential. In addition, we describe the mechanism of action of this immunotherapeutic tool with particular reference to stimulation of innate immunity through a mechanism shared by adjuvants such as Freund’s adjuvant. Finally, we describe an example of a transdermal delivery system and we discuss possible applications. *Correspondence to: Marco Ruggiero, Silver Spring Sagl, Via Raimondo Rossi 24, Arzo-Mendrisio 6864, Switzerland, Tel: +41 79 230 9283, E-mail: marco.drruggiero@gmail.com","PeriodicalId":90850,"journal":{"name":"Integrative cancer science and therapeutics","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Rationale for the design of a novel tool for immunotherapy based on an emulsion of glycosaminoglycan\",\"authors\":\"M. Ruggiero, S. Pacini\",\"doi\":\"10.15761/ICST.1000285\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this article, we describe the rationale behind the design of an innovative immunotherapeutic tool designated imunoTM that is an emulsion of microbial, lowmolecular-weight chondroitin sulfate non-covalently bound to pure phosphatidylcholine with vitamin D3 intercalated in the ensuing multi-molecular structure. The rationale for this design derives from the decade-old observation that chondroitin sulfate is the active principle responsible for the immune-stimulatory, anti-cancer properties of cartilage extracts and from the more recent observation that a known immunotherapeutic compound, the Gc protein-derived Macrophage Activating Factor (GcMAF), works as an adjuvant similar, in principle, to the incomplete Freund’s adjuvant. From these premises, we designed an innovative tool that uses an ultrapure, low-molecular-weight chondroitin sulfate, thus overcoming all limitations associated with blood-derived or animal-derived non-ultrapure extracts, at the same time guaranteeing constant sulfation profile and charge density. This novel form of chondroitin sulfate is non-covalently bound to pure phosphatidylcholine in a self-assembly manner that is coherent with the principles of negentropy. Vitamin D3 is then intercalated in this structure that resembles protocells made of a phosphatidylcholine bilayer. Such an association reduces the main side effect of vitamin D3 that is the induction of hypercalcemia, at the same time maximizing its immunotherapeutic potential. In addition, we describe the mechanism of action of this immunotherapeutic tool with particular reference to stimulation of innate immunity through a mechanism shared by adjuvants such as Freund’s adjuvant. Finally, we describe an example of a transdermal delivery system and we discuss possible applications. *Correspondence to: Marco Ruggiero, Silver Spring Sagl, Via Raimondo Rossi 24, Arzo-Mendrisio 6864, Switzerland, Tel: +41 79 230 9283, E-mail: marco.drruggiero@gmail.com\",\"PeriodicalId\":90850,\"journal\":{\"name\":\"Integrative cancer science and therapeutics\",\"volume\":\"5 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Integrative cancer science and therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/ICST.1000285\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative cancer science and therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/ICST.1000285","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
摘要
在这篇文章中,我们描述了一种创新的免疫治疗工具设计背后的基本原理,该工具被称为imunnotm,它是一种微生物乳液,低分子量硫酸软骨素与纯磷脂酰胆碱非共价结合,维生素D3插入随后的多分子结构中。这种设计的基本原理源于十年前的观察,即硫酸软骨素是软骨提取物具有免疫刺激和抗癌特性的活性原理,以及最近的观察,即一种已知的免疫治疗化合物,Gc蛋白衍生的巨噬细胞激活因子(GcMAF),原则上类似于不完整的弗氏佐剂。基于这些前提,我们设计了一种使用超纯、低分子量硫酸软骨素的创新工具,从而克服了与血源性或动物源性非超纯提取物相关的所有限制,同时保证了恒定的硫酸化轮廓和电荷密度。这种新型硫酸软骨素以一种与负熵原理相一致的自组装方式与纯磷脂酰胆碱非共价结合。维生素D3被嵌入到这个类似于磷脂酰胆碱双分子层的原始细胞的结构中。这种关联减少了维生素D3的主要副作用,即诱导高钙血症,同时最大化其免疫治疗潜力。此外,我们描述了这种免疫治疗工具的作用机制,特别提到了通过佐剂(如弗氏佐剂)共享的机制来刺激先天免疫。最后,我们描述了一个透皮给药系统的例子,并讨论了可能的应用。*通讯:Marco Ruggiero, Silver Spring Sagl, Via Raimondo Rossi 24, Arzo-Mendrisio 6864,瑞士,电话:+41 79 230 9283,E-mail: marco.drruggiero@gmail.com
Rationale for the design of a novel tool for immunotherapy based on an emulsion of glycosaminoglycan
In this article, we describe the rationale behind the design of an innovative immunotherapeutic tool designated imunoTM that is an emulsion of microbial, lowmolecular-weight chondroitin sulfate non-covalently bound to pure phosphatidylcholine with vitamin D3 intercalated in the ensuing multi-molecular structure. The rationale for this design derives from the decade-old observation that chondroitin sulfate is the active principle responsible for the immune-stimulatory, anti-cancer properties of cartilage extracts and from the more recent observation that a known immunotherapeutic compound, the Gc protein-derived Macrophage Activating Factor (GcMAF), works as an adjuvant similar, in principle, to the incomplete Freund’s adjuvant. From these premises, we designed an innovative tool that uses an ultrapure, low-molecular-weight chondroitin sulfate, thus overcoming all limitations associated with blood-derived or animal-derived non-ultrapure extracts, at the same time guaranteeing constant sulfation profile and charge density. This novel form of chondroitin sulfate is non-covalently bound to pure phosphatidylcholine in a self-assembly manner that is coherent with the principles of negentropy. Vitamin D3 is then intercalated in this structure that resembles protocells made of a phosphatidylcholine bilayer. Such an association reduces the main side effect of vitamin D3 that is the induction of hypercalcemia, at the same time maximizing its immunotherapeutic potential. In addition, we describe the mechanism of action of this immunotherapeutic tool with particular reference to stimulation of innate immunity through a mechanism shared by adjuvants such as Freund’s adjuvant. Finally, we describe an example of a transdermal delivery system and we discuss possible applications. *Correspondence to: Marco Ruggiero, Silver Spring Sagl, Via Raimondo Rossi 24, Arzo-Mendrisio 6864, Switzerland, Tel: +41 79 230 9283, E-mail: marco.drruggiero@gmail.com